1-7 of 7
Mycal Casey
Close
Sort by
Journal Articles

Are Pivotal CART Trials Representative of Population at Risk?

Anvay Shah, Vamsi K. Kota, Mycal Casey, Lorriane Odhiambo, Vishrut Shah, KM Islam, Anand Jillella, Locke Johnson Bryan, Amany R. Keruakous, Ayushi Chauhan, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 5884.
https://doi.org/10.1182/blood-2023-191122
Published: 2023
Journal Articles

Representation of the population in need for pivotal clinical trials in lymphomas

Clinical Trials & Observations
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, K. M. Islam, Jorge Cortes
Journal: Blood
Blood (2023) 142 (9): 846–855.
https://doi.org/10.1182/blood.2023020052
Published: 2023
Journal Articles

Are Pivotal Trials for Drug Approval for Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms Representative of the Population Affected By These Diseases?

Mahran Shoukier, Monirul Islam, Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 13200–13201.
https://doi.org/10.1182/blood-2022-162403
Published: 2022
Journal Articles

The Financial Toxicity of FDA-Drugs Approved for Malignant Hematology

Mahran Shoukier, Mycal Casey, Shreya Desai, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 13285–13286.
https://doi.org/10.1182/blood-2022-169316
Published: 2022
Journal Articles

Global Representation in Phase 2 and Phase 3 Clinical Trials for Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, KM Islam, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 5274–5275.
https://doi.org/10.1182/blood-2022-167092
Published: 2022
Journal Articles

Proteomics of Plasma from Patients with Sickle Cell Disease with and without Chronic Pain: A Pilot Biomarker Discovery Study

Mycal Casey, Brandon Gramazio, Florence Urum, Niren Patel, Wenbo Zhi, Abdullah Kutlar
Journal: Blood
Blood (2022) 140 (Supplement 1): 5414–5415.
https://doi.org/10.1182/blood-2022-168950
Published: 2022
Journal Articles

Are Pivotal Trials for Drugs Approved for Leukemia, Myelodysplastic Syndromes, and Multiple Myeloma Representative of the Population Demographics Affected By These Diseases?

Mycal Casey, Monirul Islam, Mahran Shoukier, Lorriane Odhiambo, Jorge E. Cortes
Journal: Blood
Blood (2021) 138 (Supplement 1): 846.
https://doi.org/10.1182/blood-2021-151235
Published: 2021